On the public citation graph
DCDB 2.0: a major update of the drug combination database
0 signed · 164 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/pst.1583openalex-snapshot
Investigation of the robustness of two models for assessing synergy in pre‐clinical drug combination studies
inferredcites →https://doi.org/10.1007/s00280-008-0913-5openalex-snapshot
Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study
inferredcites →https://doi.org/10.1016/0009-9236(95)90173-6openalex-snapshot
Effect of probenecid on the distribution and elimination of ciprofloxacin in humans
inferredcites →https://doi.org/10.1016/j.ctrv.2008.11.004openalex-snapshot
Chemotherapy for colorectal cancer in the elderly: Whom to treat and what to use
inferredcites →https://doi.org/10.1016/j.ddstr.2011.10.002openalex-snapshot
Drug repurposing from an academic perspective
inferredcites →https://doi.org/10.1016/j.drudis.2014.08.008openalex-snapshot
PubChem applications in drug discovery: a bibliometric analysis
inferredcites →https://doi.org/10.1016/s1470-2045(11)70124-3openalex-snapshot
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial
inferredcites →https://doi.org/10.1016/s1470-2045(13)70479-0openalex-snapshot
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
inferredcites →https://doi.org/10.1038/nrd1470openalex-snapshot
Can the pharmaceutical industry reduce attrition rates?
inferredcites →https://doi.org/10.1038/nrd2683openalex-snapshot
Mechanisms of drug combinations: interaction and network perspectives
inferredcites →https://doi.org/10.1056/nejmoa066838openalex-snapshot
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
inferredcites →https://doi.org/10.1073/pnas.1210419110openalex-snapshot
Defining principles of combination drug mechanisms of action
inferredcites →https://doi.org/10.1073/pnas.1337088100openalex-snapshot
Systematic discovery of multicomponent therapeutics
inferredcites →https://doi.org/10.1093/annonc/mdm086openalex-snapshot
The role of Src in prostate cancer
inferredcites →https://doi.org/10.1093/bib/bbs043openalex-snapshot
Network-based drug discovery by integrating systems biology and computational technologies
inferredcites →https://doi.org/10.1093/bioinformatics/btt353openalex-snapshot
Human interactome resource and gene set linkage analysis for the functional interpretation of biologically meaningful gene sets
inferredcites →https://doi.org/10.1093/bioinformatics/btu278openalex-snapshot
DrugComboRanker: drug combination discovery based on target network analysis
inferredcites →https://doi.org/10.1093/database/bar009openalex-snapshot
UniProt Knowledgebase: a hub of integrated protein data
inferredcites →https://doi.org/10.1093/jac/6.4.455openalex-snapshot
In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin
inferredcites →https://doi.org/10.1093/nar/gkh061openalex-snapshot
The Unified Medical Language System (UMLS): integrating biomedical terminology
inferredcites →https://doi.org/10.1093/nar/gkq1126openalex-snapshot
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
inferredcites →https://doi.org/10.1093/nar/gkr797openalex-snapshot
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery
inferredcites →https://doi.org/10.1093/nar/gkt1076openalex-snapshot
Data, information, knowledge and principle: back to metabolism in KEGG
inferredcites →https://doi.org/10.1093/nar/gkt1102openalex-snapshot
The Reactome pathway knowledgebase
inferredcites →https://doi.org/10.1093/nar/gkt1115openalex-snapshot
The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases
inferredcites →https://doi.org/10.1093/nar/gkv1351openalex-snapshot
The Reactome pathway Knowledgebase
inferredcites →https://doi.org/10.1111/ddg.12100openalex-snapshot
Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha‐2b in metastatic melanoma (phase II DeCOG trial)
inferredcites →https://doi.org/10.1111/j.1749-6632.2012.06737.xopenalex-snapshot
Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue
inferredcites →https://doi.org/10.1126/science.300.5620.740openalex-snapshot
Studying Traditional Chinese Medicine
inferredcites →https://doi.org/10.1126/scisignal.2004014openalex-snapshot
Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets
inferredcites →https://doi.org/10.1126/scitranslmed.3006548openalex-snapshot
Systems Pharmacology of Adverse Event Mitigation by Drug Combinations
inferredcites →https://doi.org/10.1136/jamia.2009.002733openalex-snapshot
An overview of MetaMap: historical perspective and recent advances
inferredcites →https://doi.org/10.1158/0008-5472.can-09-1947openalex-snapshot
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-2777openalex-snapshot
Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines
inferredcites →https://doi.org/10.1158/1535-7163.mct-12-1208openalex-snapshot
Combining Erlotinib and Cetuximab Is Associated with Activity in Patients with Non–Small Cell Lung Cancer (Including Squamous Cell Carcinomas) and Wild-TypeEGFRor Resistant Mutations
inferredcites →https://doi.org/10.1186/1471-2407-14-170openalex-snapshot
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)
inferredcites →https://doi.org/10.1186/1752-0509-5-s1-s10openalex-snapshot
Network target for screening synergistic drug combinations with application to traditional Chinese medicine
inferredcites →https://doi.org/10.1371/journal.pcbi.1000662openalex-snapshot
Network-Based Elucidation of Human Disease Similarities Reveals Common Functional Modules Enriched for Pluripotent Drug Targets
inferredcites →https://doi.org/10.1371/journal.pcbi.1002998openalex-snapshot
Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network
inferredcites →https://doi.org/10.1371/journal.pone.0042573openalex-snapshot
CDA: Combinatorial Drug Discovery Using Transcriptional Response Modules
inferredcites →https://doi.org/10.4051/ibc.2013.5.2.0003openalex-snapshot
Systematic approach for analyzing drug combination by using target-enzyme distance
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/1878-0261.12524openalex-snapshot
Alternative splicing in human cancer cells is modulated by the amiloride derivative 3,5‐diamino‐6‐chloro‐N‐(N‐(2,6‐dichlorobenzoyl)carbamimidoyl)pyrazine‐2‐carboxide
inferred← citeshttps://doi.org/10.1002/ddr.21738openalex-snapshot
Combining kinase inhibitors for optimally co‐targeting cancer and drug escape by exploitation of drug target promiscuities
inferred← citeshttps://doi.org/10.1007/978-1-0716-0849-4_12openalex-snapshot
Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models
inferred← citeshttps://doi.org/10.1007/978-981-16-0753-0_6openalex-snapshot
Network Pharmacology and Modern Drug R&D Cases
inferred← citeshttps://doi.org/10.1007/978-981-19-0105-8_2openalex-snapshot
MultiNet: A Diffusion-Based Approach to Assign Directionality in Protein Interactions Using a Consensus of Eight Protein Interaction Datasets
inferred← citeshttps://doi.org/10.1007/s00044-024-03260-wopenalex-snapshot
In silico drug discovery: a machine learning-driven systematic review
inferred← citeshttps://doi.org/10.1007/s10910-022-01331-0openalex-snapshot
A machine learning framework for predicting synergistic and antagonistic drug combinatorial efficacy
inferred← citeshttps://doi.org/10.1007/s11042-023-15723-0openalex-snapshot
Performance evaluation of drug synergy datasets using computational intelligence approaches
inferred← citeshttps://doi.org/10.1007/s12539-021-00422-xopenalex-snapshot
An In Silico Method for Predicting Drug Synergy Based on Multitask Learning
inferred← citeshttps://doi.org/10.1007/s13748-024-00314-3openalex-snapshot
DCGG: drug combination prediction using GNN and GAE
inferred← citeshttps://doi.org/10.1007/s40005-016-0286-4openalex-snapshot
Rationale and strategies for formulation development of oral fixed dose combination drug products
inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.11569-7openalex-snapshot
Drug Combination Modeling
inferred← citeshttps://doi.org/10.1016/b978-0-12-801814-9.00003-9openalex-snapshot
Holistic Drug Targeting
inferred← citeshttps://doi.org/10.1016/b978-0-12-805274-7.00002-6openalex-snapshot
Data characterization
inferred← citeshttps://doi.org/10.1016/b978-0-12-809633-8.20665-1openalex-snapshot
Preclinical: Drug Target Identification and Validation in Human
inferred← citeshttps://doi.org/10.1016/b978-0-12-820472-6.00116-xopenalex-snapshot
Magic bullets: Drug repositioning and drug combinations
inferred← citeshttps://doi.org/10.1016/b978-0-12-820576-1.00001-1openalex-snapshot
Combination therapy: Current status and future perspectives
inferred← citeshttps://doi.org/10.1016/j.bspc.2026.110119openalex-snapshot
MFMHIN: Predicting synergistic drug combinations via biologically-aware heterogeneous information networks
inferred← citeshttps://doi.org/10.1016/j.cmpb.2018.11.002openalex-snapshot
Predicting combinative drug pairs via multiple classifier system with positive samples only
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2022.105503openalex-snapshot
Generalized matrix factorization based on weighted hypergraph learning for microbe-drug association prediction
inferred← citeshttps://doi.org/10.1016/j.coph.2018.07.008openalex-snapshot
Recent advances in combinatorial drug screening and synergy scoring
inferred← citeshttps://doi.org/10.1016/j.csbj.2021.07.003openalex-snapshot
Machine learning in the prediction of cancer therapy
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.06.002openalex-snapshot
Using response surface models to analyze drug combinations
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.07.023openalex-snapshot
The optimization of combinatorial drug therapies: Strategies and laboratorial platforms
inferred← citeshttps://doi.org/10.1016/j.fct.2026.116050openalex-snapshot
Combining UHPLC profiling and random walk network-based in vitro analysis to predict herb-induced liver injury
inferred← citeshttps://doi.org/10.1016/j.jconrel.2023.04.006openalex-snapshot
HDACIs and TKIs combinations and their liposomal delivery for cancer treatment
inferred← citeshttps://doi.org/10.1016/j.jtbi.2017.01.019openalex-snapshot
PDC-SGB: Prediction of effective drug combinations using a stochastic gradient boosting algorithm
inferred← citeshttps://doi.org/10.1016/j.synbio.2024.09.003openalex-snapshot
Predicting effective drug combinations for cancer treatment using a graph-based approach
inferred← citeshttps://doi.org/10.1021/acs.jcim.3c01613openalex-snapshot
Network-Based Methods and Their Applications in Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jcim.5c01310openalex-snapshot
DGSS: A Dynamic Interaction Graph Neural Network with Specific Substructure Awareness for Drug Synergy Prediction
inferred← citeshttps://doi.org/10.1021/acs.jcim.6c01470openalex-snapshot
HyperDC: A Non-Uniform Hypergraph Framework for Dual- and Higher-Order Drug Combination Recommendation Across Diverse Complex Diseases
inferred← citeshttps://doi.org/10.1021/acs.jcim.9b00793openalex-snapshot
Incorporating Multisource Knowledge To Predict Drug Synergy Based on Graph Co-regularization
inferred← citeshttps://doi.org/10.1038/ncomms9481openalex-snapshot
Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer
inferred← citeshttps://doi.org/10.1038/s41597-022-01360-zopenalex-snapshot
CDCDB: A large and continuously updated drug combination database
inferred← citeshttps://doi.org/10.1038/s41597-025-05630-4openalex-snapshot
A highly annotated drug combination resource for catalyzing precision combinatorial therapy
inferred← citeshttps://doi.org/10.1038/s41598-018-19614-5openalex-snapshot
In silico profiling of systemic effects of drugs to predict unexpected interactions
inferred← citeshttps://doi.org/10.1038/s41598-018-30138-wopenalex-snapshot
Phenotype-oriented network analysis for discovering pharmacological effects of natural compounds
inferred← citeshttps://doi.org/10.1038/s41598-024-52814-wopenalex-snapshot
Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs
inferred← citeshttps://doi.org/10.1038/s41698-020-0122-1openalex-snapshot
Machine learning approaches to drug response prediction: challenges and recent progress
inferred← citeshttps://doi.org/10.1039/c5mb00599jopenalex-snapshot
Synergy evaluation by a pathway–pathway interaction network: a new way to predict drug combination
inferred← citeshttps://doi.org/10.1039/c9np00011aopenalex-snapshot
Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2
inferred← citeshttps://doi.org/10.1053/j.gastro.2016.09.065openalex-snapshot
Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases
inferred← citeshttps://doi.org/10.1080/17460441.2018.1413089openalex-snapshot
Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery
inferred← citeshttps://doi.org/10.1093/bib/bbab355openalex-snapshot
Machine learning methods, databases and tools for drug combination prediction
inferred← citeshttps://doi.org/10.1093/bib/bbac075openalex-snapshot
A review of machine learning approaches for drug synergy prediction in cancer
inferred← citeshttps://doi.org/10.1093/bib/bbac403openalex-snapshot
Predicting cell line-specific synergistic drug combinations through a relational graph convolutional network with attention mechanism
inferred← citeshttps://doi.org/10.1093/bib/bbad285openalex-snapshot
A model-agnostic framework to enhance knowledge graph-based drug combination prediction with drug–drug interaction data and supervised contrastive learning
inferred← citeshttps://doi.org/10.1093/bib/bbad364openalex-snapshot
Latent space search based multimodal optimization with personalized edge-network biomarker for multi-purpose early disease prediction
inferred← citeshttps://doi.org/10.1093/bib/bbx047openalex-snapshot
Advances in computational approaches in identifying synergistic drug combinations
inferred← citeshttps://doi.org/10.1093/bib/bby046openalex-snapshot
Evaluating the consistency of large-scale pharmacogenomic studies
inferred← citeshttps://doi.org/10.1093/bib/bby061openalex-snapshot
Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases
inferred← citeshttps://doi.org/10.1093/bib/bbz091openalex-snapshot
Heterogeneous information network and its application to human health and disease
inferred← citeshttps://doi.org/10.1093/bioadv/vbaf269openalex-snapshot
DSA-DeepFM: a dual-stage attention-enhanced DeepFM model for predicting anticancer synergistic drug combinations
inferred← citeshttps://doi.org/10.1093/bioinformatics/btac538openalex-snapshot
Multidrug representation learning based on pretraining model and molecular graph for drug interaction and combination prediction
inferred← citeshttps://doi.org/10.1093/bioinformatics/btaf215openalex-snapshot
HIG-Syn: a hypergraph and interaction-aware multigranularity network for predicting synergistic drug combinations
inferred← citeshttps://doi.org/10.1093/bioinformatics/btx806openalex-snapshot
DeepSynergy: predicting anti-cancer drug synergy with Deep Learning
inferred← citeshttps://doi.org/10.1093/bioinformatics/btz091openalex-snapshot
Response envelope analysis for quantitative evaluation of drug combinations
inferred← citeshttps://doi.org/10.1093/database/baae102openalex-snapshot
CPMKG: a condition-based knowledge graph for precision medicine
inferred← citeshttps://doi.org/10.1093/database/baaf043openalex-snapshot
DrugCombo: an informatics bridge for anticancer drug combination Phase I trial design
inferred← citeshttps://doi.org/10.1093/database/baz044openalex-snapshot
CANCROX: a cross-species cancer therapy database
inferred← citeshttps://doi.org/10.1093/jamia/ocy074openalex-snapshot
A systematic assessment of the availability and clinical drug information coverage of machine-readable clinical drug data sources for building knowledge translation products
inferred← citeshttps://doi.org/10.1093/nar/gkaa1272openalex-snapshot
Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients
inferred← citeshttps://doi.org/10.1093/nar/gkab913openalex-snapshot
NPCDR: natural product-based drug combination and its disease-specific molecular regulation
inferred← citeshttps://doi.org/10.1093/nar/gkae791openalex-snapshot
DrugMAP 2.0: molecular atlas and pharma-information of all drugs
inferred← citeshttps://doi.org/10.1093/nar/gkz1007openalex-snapshot
DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy
inferred← citeshttps://doi.org/10.1101/2020.05.12.092239openalex-snapshot
Personalized anti-cancer drug combination prediction by an Integrated Multi-level Network
inferred← citeshttps://doi.org/10.1101/2020.09.13.295063openalex-snapshot
RWRDC: Predicting Efficacious Drug Combinations in Cancer Based on Random Walk with Restart
inferred← citeshttps://doi.org/10.1101/2020.12.10.420760openalex-snapshot
HRWR: Predicting Potential Efficacious Drug Combination Based on Hypergraph Random Walk with Restart
inferred← citeshttps://doi.org/10.1101/2021.02.25.432979openalex-snapshot
IHRW: An Improved Hypergraph Random Walk Model for Predicting Three-Drug Therapy
inferred← citeshttps://doi.org/10.1101/2021.04.11.439315openalex-snapshot
DruID: Personalized Dru g Recommendations by I ntegrating Multiple Biomedical D atabases for Cancer
inferred← citeshttps://doi.org/10.1101/2023.08.15.553383openalex-snapshot
Predicting human microbe-drug associations via graph attention network with multiple kernel fusion
inferred← citeshttps://doi.org/10.1101/477547openalex-snapshot
DrugCombDB: a comprehensive database of drug combinations toward network medicine and combination therapy
inferred← citeshttps://doi.org/10.1101/571620openalex-snapshot
A novel network controllability algorithm to target personalized driver genes for discovering combinational drugs of individual cancer patient
inferred← citeshttps://doi.org/10.1109/access.2018.2874089openalex-snapshot
A Data-Driven Approach for Identifying Medicinal Combinations of Natural Products
inferred← citeshttps://doi.org/10.1109/bibm.2018.8621087openalex-snapshot
A Gene Family-led Meta-Analysis of Drug-Target Interactions
inferred← citeshttps://doi.org/10.1109/cibcb66090.2025.11177071openalex-snapshot
CombDNF: Disease-Specific drug combination predictions with network-based features on clinically validated data
inferred← citeshttps://doi.org/10.1109/icwr54782.2022.9786240openalex-snapshot
Dcomg: Drug Combination Prediction by Applying Gnns on DDI Node2vec Features
inferred← citeshttps://doi.org/10.1109/jbhi.2018.2852274openalex-snapshot
Ensemble Prediction of Synergistic Drug Combinations Incorporating Biological, Chemical, Pharmacological, and Network Knowledge
inferred← citeshttps://doi.org/10.1109/tcbb.2019.2933825openalex-snapshot
An Analytical Review of Computational Drug Repurposing
inferred← citeshttps://doi.org/10.1109/tcbb.2019.2951557openalex-snapshot
Inferring Synergistic Drug Combinations Based on Symmetric Meta-Path in a Novel Heterogeneous Network
inferred← citeshttps://doi.org/10.1109/tcbb.2022.3224734openalex-snapshot
A Drug Combination Prediction Framework Based on Graph Convolutional Network and Heterogeneous Information
inferred← citeshttps://doi.org/10.1109/tcbbio.2025.3640539openalex-snapshot
SOCAR: Network-Based Computational Framework to Overcome Acquired Tamoxifen Resistance of MCF7 Cells
inferred← citeshttps://doi.org/10.1109/tevc.2024.3414442openalex-snapshot
A Survey on Evolutionary Computation for Identifying Biomarkers of Complex Disease
inferred← citeshttps://doi.org/10.1142/s0219720019500124openalex-snapshot
Predicting drug synergy for precision medicine using network biology and machine learning
inferred← citeshttps://doi.org/10.1142/s0219720023500142openalex-snapshot
Drug synergy model for malignant diseases using deep learning
inferred← citeshttps://doi.org/10.1146/annurev-pharmtox-010818-021511openalex-snapshot
Systems Pharmacology: Defining the Interactions of Drug Combinations
inferred← citeshttps://doi.org/10.1146/annurev-pharmtox-010919-023746openalex-snapshot
Artificial Intelligence in Drug Treatment
inferred← citeshttps://doi.org/10.1155/2016/8518945openalex-snapshot
Biomolecular Network-Based Synergistic Drug Combination Discovery
inferred← citeshttps://doi.org/10.1155/2018/4028473openalex-snapshot
The Prediction of Drug-Disease Correlation Based on Gene Expression Data
inferred← citeshttps://doi.org/10.1186/s12859-019-3288-1openalex-snapshot
Predicting effective drug combinations using gradient tree boosting based on features extracted from drug-protein heterogeneous network
inferred← citeshttps://doi.org/10.1186/s12906-024-04503-4openalex-snapshot
Predicting herb-disease associations using network-based measures in human protein interactome
inferred← citeshttps://doi.org/10.1186/s12911-017-0449-xopenalex-snapshot
Network mirroring for drug repositioning
inferred← citeshttps://doi.org/10.1186/s12918-016-0326-8openalex-snapshot
Drug combinatorics and side effect estimation on the signed human drug-target network
inferred← citeshttps://doi.org/10.1186/s12967-024-05660-3openalex-snapshot
A weighted Bayesian integration method for predicting drug combination using heterogeneous data
inferred← citeshttps://doi.org/10.1186/s13321-019-0339-6openalex-snapshot
CSgator: an integrated web platform for compound set analysis
inferred← citeshttps://doi.org/10.1186/s13765-024-00961-zopenalex-snapshot
Prediction of bioactive compounds hepatotoxicity using in silico and in vitro analysis
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1005522openalex-snapshot
Detecting similar binding pockets to enable systems polypharmacology
inferred← citeshttps://doi.org/10.1371/journal.pone.0150460openalex-snapshot
Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures
inferred← citeshttps://doi.org/10.2174/0929867326666190808154841openalex-snapshot
Survey of Similarity-Based Prediction of Drug-Protein Interactions
inferred← citeshttps://doi.org/10.2174/1574892818666221018091415openalex-snapshot
Prediction of Cancer Treatment Using Advancements in Machine Learning
inferred← citeshttps://doi.org/10.22214/ijraset.2021.38203openalex-snapshot
Drug Classification using Black-box models and Interpretability
inferred← citeshttps://doi.org/10.29322/ijsrp.10.02.2020.p9813openalex-snapshot
FEATURIZATION OF DRUG COMPOUNDS AND TARGET PROTEINS FOR DRUG-TARGET INTERACTION PREDICTION
inferred← citeshttps://doi.org/10.3389/fcell.2020.00368openalex-snapshot
Reveal the Regulation Patterns of Prognosis-Related miRNAs and lncRNAs Across Solid Tumors in the Cancer Genome Atlas
inferred← citeshttps://doi.org/10.3389/fcimb.2018.00424openalex-snapshot
MDAD: A Special Resource for Microbe-Drug Associations
inferred← citeshttps://doi.org/10.3389/fgene.2019.00600openalex-snapshot
Five-Feature Model for Developing the Classifier for Synergistic vs. Antagonistic Drug Combinations Built by XGBoost
inferred← citeshttps://doi.org/10.3389/fgene.2019.00829openalex-snapshot
Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines
inferred← citeshttps://doi.org/10.3389/fgene.2020.01000openalex-snapshot
A Machine Learning Method for Drug Combination Prediction
inferred← citeshttps://doi.org/10.3390/cancers13143586openalex-snapshot
Systems Pharmacology-Based Precision Therapy and Drug Combination Discovery for Breast Cancer
inferred← citeshttps://doi.org/10.3390/cancers14082043openalex-snapshot
Integrated Network Pharmacology Approach for Drug Combination Discovery: A Multi-Cancer Case Study
inferred← citeshttps://doi.org/10.3390/ijms19020467openalex-snapshot
Prediction of Effective Drug Combinations by an Improved Naïve Bayesian Algorithm
inferred← citeshttps://doi.org/10.3390/ijms232113568openalex-snapshot
Application of Computational Biology and Artificial Intelligence in Drug Design
inferred← citeshttps://doi.org/10.3390/ijms25137298openalex-snapshot
Insight into Mantle Cell Lymphoma Pathobiology, Diagnosis, and Treatment Using Network-Based and Drug-Repurposing Approaches
inferred← citeshttps://doi.org/10.3390/molecules23040736openalex-snapshot
Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes
inferred← citeshttps://doi.org/10.3390/molecules23092208openalex-snapshot
Machine Learning for Drug-Target Interaction Prediction
inferred← citeshttps://doi.org/10.3390/molecules24091714openalex-snapshot
Revealing Drug-Target Interactions with Computational Models and Algorithms
inferred← citeshttps://doi.org/10.3390/nu10081042openalex-snapshot
Discovering Health Benefits of Phytochemicals with Integrated Analysis of the Molecular Network, Chemical Properties and Ethnopharmacological Evidence
inferred← citeshttps://doi.org/10.3390/pharmaceutics11050208openalex-snapshot
Drug Combinations: Mathematical Modeling and Networking Methods
inferred← citeshttps://doi.org/10.34133/csbj.0193openalex-snapshot
Integrated Approaches in Drug Repositioning Highlight Ouabain and Helenalin as Potential Drug Candidates for Pulmonary Fibrosis
inferred← citeshttps://doi.org/10.3724/bnsfc-2025.05.14.0002openalex-snapshot
Current Status and Prospects of Combination Drug and Its Artificial Intelligence Algorithm Development
inferred← citeshttps://doi.org/10.48550/arxiv.1912.03281openalex-snapshot
The mathematical structure of innovation
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.